Trials / Sponsors / John Mascarenhas
John Mascarenhas
Academic / Other · 11 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | Phase 2 | 2026-05-04 |
| Recruiting | Study of Canakinumab in Patients With Myelofibrosis Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF | Phase 2 | 2022-08-02 |
| Completed | Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Ch Accelerated/Blast-phase Myeloproliferative Neoplasm, Chronic-phase Myelofibrosis, IDH2 Mutation | Phase 2 | 2021-01-14 |
| Completed | MPN-RC 118 AVID200 in Myelofibrosis Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Phase 1 | 2019-02-15 |
| Completed | PD-1 Inhibition in Advanced Myeloproliferative Neoplasms Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | Phase 2 | 2017-06-14 |
| Completed | Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia Polycythemia Vera, Essential Thrombocythemia | Phase 1 | 2015-04-01 |
| Completed | Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML Myeloproliferative Neoplasms | Phase 1 / Phase 2 | 2014-02-01 |
| Terminated | Ruxolitinib Prior to Transplant in Patients With Myelofibrosis Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis | Phase 2 | 2013-11-01 |
| Completed | Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial) Myelofibrosis | Phase 1 / Phase 2 | 2013-01-01 |
| Terminated | Anti-TGF-beta Therapy in Patients With Myelofibrosis Myelofibrosis, Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Phase 1 | 2011-02-01 |
| Completed | Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis Myelofibrosis | Phase 2 | 2007-08-01 |